A multi-center, randomized, double blind, placebo-controlled study of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in children with systemic juvenile idiopathic arthritis
ANNALS OF THE RHEUMATIC DISEASES（2006）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined